Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature

Autoimmunity Reviews

Volumn 4, Issue 2, 2005, Pages 111-115

  Costedoat Chalumeau, Nathalie ^a   Amoura, Zahir ^a   Huong, Du Le Thi ^a   Lechat, Philippe ^a   Piette, Jean Charles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Connective tissue diseases; Hydroxychloroquine; Lactation; Pregnancy

Indexed keywords

ANTIMALARIAL AGENT; HYDROXYCHLOROQUINE;

BIRTH DEFECT; BREAST FEEDING; CLINICAL PRACTICE; CONGENITAL MALFORMATION; CONNECTIVE TISSUE DISEASE; DISEASE EXACERBATION; DRUG SAFETY; EYE TOXICITY; FETUS MALFORMATION; HEALTH SURVEY; HUMAN; LACTATION; MEDICAL LITERATURE; NONHUMAN; OTOTOXICITY; PREGNANCY; PRENATAL EXPOSURE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 13844296727     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2004.11.009     Document Type: Review

References (25)

1. The Canadian Hydroxychloroquine Study Group A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus N. Engl. J. Med. 324 1991 150 154
2. N. Costedoat-Chalumeau, Z. Amoura, G. Aymard, T.H. Le, B. Wechsler, and D. Vauthier Evidence of transplacental passage of hydroxychloroquine in humans Arthritis Rheum. 46 4 2002 1123 1124
3. S.E. Tett, D.J. Cutler, R.O. Day, and K.F. Brown Bioavailability of hydroxychloroquine tablets in healthy volunteers Br. J. Clin. Pharmacol. 27 1989 771 779
4. Physician's Desk Reference [online]. Accessed January, 2003.URL: www.pdr.net.
5. R. Roubenoff, J. Hoyt, M. Petri, M.C. Hochberg, and D.B. Hellmann Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility Semin. Arthritis Rheum. 18 1988 88 110
6. P.A. Phillips-Howard, and D. Wood The safety of antimalarial drugs in pregnancy Drug Saf. 14 1996 131 145
7. G.J. Matz, and R.F. Naunton Ototoxicity of chloroquine Arch. Otolaryngol. 88 1968 370 372
8. A.L. Parke Antimalarial drugs, systemic lupus erythematosus and pregnancy J. Rheumatol. 15 1988 607 610
9. A. Parke Antimalarial drugs and pregnancy Am. J. Med. 85 1988 30 33
10. A. Parke, and B. West Hydroxychloroquine in pregnant patients with systemic lupus erythematosus J. Rheumatol. 23 1996 1715 1718
11. N.M. Buchanan, E. Toubi, M.A. Khamashta, F. Lima, S. Kerslake, and G.R. Hughes Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases Ann. Rheum. Dis. 55 1996 486 488
12. M. Motta, A. Tincani, D. Faden, E. Zinzini, and G. Chirico Antimalarial agents in pregnancy Lancet 359 2002 524 525
13. G. Klinger, Y. Morad, C.A. Westall, C. Laskin, K.A. Spitzer, and G. Koren Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases Lancet 358 9284 2001 813 814
14. R.A. Levy, V.S. Vilela, M.J. Cataldo, R.C. Ramos, J.L. Duarte, and B.R. Tura Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study Lupus 10 6 2001 401 404
15. N. Costedoat-Chalumeau, Z. Amoura, P. Duhaut, L.T. Huong du, D. Sebbough, and B. Wechsler Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group Arthritis Rheum. 48 11 2003 3207 3211
16. M. Frassi, C. Biasini, M. Taglietti, E. Danieli, D. Faden, and A. Lojacono Hydroxychloroquine in pregnant patients with rheumatic disease: a case control observation of 76 treated pregnancies (abstract) Lupus 13 9 2004 755
17. M.E. Clowse, L.S. Magder, and M. Petri The effect of Hydroxychloroquine on pregnancy outcomes and disease activity in lupus patients (abstract) Arthritis Rheum. 50 2004 689 690
18. Report 8: Surveillance of Congenital Anomalies in Europe 1980-1999. In: E.W. Group, ed. EUROCAT: University of Ulster, 2002 [online]. Accessed April, 2003. URL: www.eurocat.ulster.ac.uk/pubdata/report8tab.html.
19. R. Cimaz, A. Brucato, E. Meregalli, M. Muscara, and P. Sergi Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: comment on the article by Costedoat-Chalumeau et al. Arthritis Rheum. 50 2004 3056 3057 [author reply 3057-8]
20. N. Costedoat-Chalumeau, Z. Amoura, D. Sebbough, and J.C. Piette Reply Arthritis Rheum. 50 2004 3057
21. M. Motta, A. Tincani, D. Faden, E. Zinzini, A. Lojacono, and A. Marchesi Follow-up of infants exposed to Hydroxychloroquine given to mothers during pregnancy and lactation J. Perinatol. 14 2004 14
22. Case records of the Massachusetts General Hospital Weekly clinicopathological exercises. Case 38-1988. A 58-year-old woman with fever, sweats, congestive heart failure, and lymphadenopathy after treatment for a diagnosis of systemic lupus erythematosus N. Engl. J. Med. 319 1988 768 781
23. R.L. Nation, L.P. Hackett, L.J. Dusci, and K.F. Ilett Excretion of hydroxychloroquine in human milk Br. J. Clin. Pharmacol. 17 1984 368 369
24. A. Al-Herz, M. Schulzer, and J.M. Esdaile Survey of antimalarial use in lupus pregnancy and lactation J. Rheumatol. 29 2002 700 706
25. M. Ostensen Disease specific problems related to drug therapy in pregnancy Lupus 13 2004 746 750